Glimepride 2 mg + Metformin 500 SR+ Pioglitazone 15 mg
INR 1050
In stock
Description
GLIMSTRIP-MP2 Tablets is an advanced triple-drug antidiabetic formulation designed for comprehensive glycemic control in Type 2 Diabetes Mellitus. Glimepiride stimulates insulin secretion, Metformin reduces hepatic glucose production, and Pioglitazone improves insulin sensitivity.
The bilayered sustained-release design ensures stable blood glucose control, reduced GI side effects, and better patient compliance. GLIMSTRIP-MP2 is ideal for patients with poor glycemic control on dual therapy.
Marketed by Varmed Pharma Pvt Ltd, it is a profitable diabetic care brand for PCD Pharma Franchise partners.
